4 recruiting, 1 not yet recruiting. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 2 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Epigenetic Aging: new trials by email Literature Review of Epigenetic Aging trials Research Report on Epigenetic Aging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Switch to Doravirine/Islatravir vs. Continued Antiretroviral Therapy on Biomarkers of Aging Among Virologically Suppressed People With HIV Switch from an ART regimen containing lamivudine (3TC) or emtricitabine (FTC) + tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) to DOR/ISL, Switch from an nucleoside reverse transcriptase inhibitor (NRTI)-sparing ART regimen containing greater than or equal to 2 drugs to DOR/ISL, Continue SoC ART - Epigenetic Aging | Phase 2 | Not yet recruiting | The University of Texas Health Science Center, Houston | 60 | 2026-10-30 | 2026-10-23 |
| Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging Aging, Epigenetic Aging | Recruiting | IVI Murcia | 45 | 2026-06-10 | 2026-09-10 | |
| Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging fasting mimicking diet - Fat Mass, Risk Factors Cardiovascular Disease | Not applicable | Recruiting | Fondazione Valter Longo | 135 | 2025-05-02 | 2025-12-01 |
| The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families Promoting First Relationships in Primary Care (PFR-PC) - Parent Child Relationship, Child Social-Emotional Development | Not applicable | Recruiting | University of Washington | 250 | 2024-12-13 | 2026-02-06 |
| Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial TRIIM Treatment, Active Control - Epigenetic Aging, Immunosenescence | Phase 2 | Recruiting | Intervene Immune, Inc. | 85 | 2020-11-23 | 2025-05-07 |
Disease (1) · Fasting (1) · Infertility (1) · Obesity (1) · Overweight (1) · Risk-Taking (1)
Behavior (1) · Body Weight (1) · Feeding Behavior (1) · Genital Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urogenital Diseases (1)
Primary Health Care (1) · Racivir (1) · Tenofovir (1) · tenofovir alafenamide (1)
Fondazione Valter Longo (1) · IVI Murcia (1) · Intervene Immune, Inc. (1) · The University of Texas Health Science Center, Houston (1) · University of Washington (1)
United States (3) · Italy (1) · Spain (1)
Alberto Montesanto (1) · Jordan E Lake, MD, MSc (1) · Monica Oxford, PhD (1)
PMID 15383513, PMID 18265475, PMID 22645105, PMID 24606898, PMID 24962851, PMID 26094889, PMID 28202779
R01NR021020 (1)